SuperworthAxogen profit margin AXGN
Gross, operating and net profit as a share of revenue over the last twelve months, from 2015.
- Net margin, 12 months
- −13.4%
- Operating margin, 12 months
- −5.1%
- Net margin on a year earlier
- −11.1 pts
- Peer median
- 11.1%
Over the twelve months to Jun 30, 2026, Axogen kept −13.4% of its revenue as net profit, with an operating margin of −5.1% and a gross margin of 74.6%.
Five years earlier its net margin was −16.9%.
The median for 6 medical device stocks of a similar size is 11.1%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −7.0% | −3.5% | 74.3% |
| FY2024 | −5.3% | −1.8% | 75.8% |
| FY2023 | −13.7% | −13.5% | 76.6% |
| FY2022 | −20.9% | −21.4% | 82.6% |
| FY2021 | −21.2% | −20.0% | 82.0% |
| FY2020 | −21.2% | −20.6% | 80.8% |
| FY2019 | −27.3% | −29.4% | 83.7% |
| FY2018 | −26.7% | −24.4% | 84.6% |
| FY2017 | −17.3% | −13.2% | 84.6% |
| FY2016 | −35.1% | −19.8% | 84.3% |
| FY2015 | −48.9% | −33.9% | 82.3% |
| FY2014 | n/a | −58.3% | 79.5% |
| FY2013 | n/a | −87.6% | 77.7% |
| FY2012 | n/a | n/a | 74.5% |
| FY2011 | n/a | n/a | 50.0% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −13.4% | −11.1 pts | −5.1% | |
| Q1 FY26 | −13.2% | −9.5 pts | −3.8% | |
| Q4 FY25 | −7.0% | −1.7 pts | −3.5% | |
| Q3 FY25 | −1.0% | +6.9 pts | 1.8% | |
| Q2 FY25 | −2.3% | +7.2 pts | 0.8% | |
| Q1 FY25 | −3.7% | +9.3 pts | −0.2% | |
| Q4 FY24 | −5.3% | +8.3 pts | −1.8% | |
| Q3 FY24 | −7.9% | +7.4 pts | −4.7% | |
| Q2 FY24 | −9.5% | +6.3 pts | −7.0% | |
| Q1 FY24 | −13.0% | +4.0 pts | −11.4% | |
| Q4 FY23 | −13.7% | +7.2 pts | −13.5% | |
| Q3 FY23 | −15.3% | +6.3 pts | −15.7% |
Against its peers
Companies in Medical - Devices nearest Axogen's size, closest first, today.
| Company | Profit margin |
|---|---|
| AXGNAxogen | −13.4% |
| TMDXTransMedics | 22.7% |
| CNMDCONMED | 4.1% |
| ITGRInteger | 7.0% |
| LIVNLivaNova | 12.8% |
| ZBHZimmer Biomet | 9.5% |
| ELMDElectromed | 15.3% |
| Peer median | 11.1% |
Where Axogen ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Axogen
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.